Cargando…
Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India
BACKGROUND: Diabetes is recognized as an important comorbidity in patients with COVID-19 and a large amount of literature has become available regarding this. The aim of this article is to review the literature regarding various aspects of association between diabetes and COVID-19 and to highlight c...
Autores principales: | Gupta, Ritesh, Misra, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477599/ https://www.ncbi.nlm.nih.gov/pubmed/32942253 http://dx.doi.org/10.1016/j.dsx.2020.09.009 |
Ejemplares similares
-
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India
por: Ghosh, Amerta, et al.
Publicado: (2020) -
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
por: Gupta, Ritesh, et al.
Publicado: (2020) -
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Ghosh, Amerta, et al.
Publicado: (2020) -
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
por: Ghosh, Amerta, et al.
Publicado: (2020)